Drug
Oncology Update: regorafenib improves survival in metastatic colorectal cancer (mCRC)
According to a press release issued by Onyx Pharmaceuticals, Inc. on October 25, 2011 a Phase 3 trial with regorafenib in metastatic colorectal cancer (mCRC) patients being conducted by Bayer HealthCare Pharmaceuticals met its primary endpoint of improved overall survival. Apparently, this trial’s independent Data Monitoring Committee... Read more of this article
Oncology Update: ADCETRIS(TM) Brentuximab Vedotin
We have completed our preliminary assessment of the FDA approved oncology drug ADCETRIS (TM) Brentuximab Vedotin using BioHorizon’s proprietary assessment methodology and have designated this oncology therapeutic agent as High Impact. Given the observed treatment effect in pivotal clinical trials we see potential for rapid uptake by oncologists responsible... Read more of this article
Amylin, Lilly, and Alkermes Await FDA Decision on Byetta for Diabetes
On February 25th, 2010, Amylin, Lilly, and Alkermes announced in a press release that the FDA had set March 12th 2010 as the Prescription Drug User Fee Act (PDUFA) action date for Byetta’s long acting formulation – exenatide once weekly. Our readers will recall that Byetta is used by type 2 diabetics for glycemic (blood glucose)... Read more of this article
More Posts From Drug
Vaccine
Wyeth vs. GSK: A Vaccine Showdown?
Today Biohorizon will take its first look at two new vaccines that promise to make...
MedImmune’s CAIV-T Influenza Vaccine
On November 1, 2004 MedImmune announced that enrollment in its Phase 3 CAIV-T influenza...
ID Biomedical’s FluInsure Influenza Vaccine
FluInsure™ On July 20 2004, ID Biomedical released preliminary data regarding FluInsure™...
More Posts From Vaccine
Diagnostic Test
Matritech’s NMP179 for Detection of Cervical Cancer
On May 10, 2004 Matritech announced the beginning of clinical testing of 10,000 samples...
OraQuick Rapid HIV Antibody Test
On March 26, 2004 OraSure Technologies, Inc. announced that it has received U.S....
More Posts From Diagnostic Test
